These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 27127487)
1. "Warming yang and invigorating qi" acupuncture alters acetylcholine receptor expression in the neuromuscular junction of rats with experimental autoimmune myasthenia gravis. Huang HP; Pan H; Wang HF Neural Regen Res; 2016 Mar; 11(3):465-8. PubMed ID: 27127487 [TBL] [Abstract][Full Text] [Related]
2. Invigorating spleen, replenishing qi and tonifying kidney method treatment of traditional Chinese medicine for myasthenia gravis: A protocol for systematic review and meta-analysis. Liu M; Wang H; Lv Z; Lu J; Zhang D; Zhu Z; Wu C; Tian Y; Song C; Wu T; Liu L; Chen X Medicine (Baltimore); 2022 Dec; 101(50):e32285. PubMed ID: 36550924 [TBL] [Abstract][Full Text] [Related]
3. [Acupuncture combined with western medication for ocular myasthenia gravis: a randomized controlled trial]. Xu XP; Jiang YB; Guan LH; Ji QJ; Jin Y Zhongguo Zhen Jiu; 2022 Jul; 42(7):755-9. PubMed ID: 35793884 [TBL] [Abstract][Full Text] [Related]
4. Possible implications of dysregulated nicotinic acetylcholine receptor diffusion and nanocluster formation in myasthenia gravis. Barrantes FJ Neural Regen Res; 2021 Feb; 16(2):242-246. PubMed ID: 32859770 [TBL] [Abstract][Full Text] [Related]
5. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395 [TBL] [Abstract][Full Text] [Related]
6. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study. Engel AG; Tsujihata M; Lindstrom JM; Lennon VA Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997 [TBL] [Abstract][Full Text] [Related]
7. Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets. Paz ML; Barrantes FJ ACS Chem Neurosci; 2019 May; 10(5):2186-2194. PubMed ID: 30916550 [TBL] [Abstract][Full Text] [Related]
8. The mouse passive-transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure. Ghazanfari N; Trajanovska S; Morsch M; Liang SX; Reddel SW; Phillips WD Ann N Y Acad Sci; 2018 Jan; 1412(1):54-61. PubMed ID: 29125188 [TBL] [Abstract][Full Text] [Related]
9. The immunopathology of myasthenia gravis. Lennon VA Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428 [TBL] [Abstract][Full Text] [Related]
10. The role of acetylcholine receptor antibodies in myasthenia gravis. Appel SH; Elias SB; Chauvin P Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014 [TBL] [Abstract][Full Text] [Related]
11. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis. Kelly JJ; Lambert EH; Lennon VA Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931 [TBL] [Abstract][Full Text] [Related]
12. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study. Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL; BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795 [TBL] [Abstract][Full Text] [Related]
13. Decreased number of acetylcholine receptors is the mechanism that alters the time course of muscle relaxants in myasthenia gravis: a study in a rat model. De Haes A; Proost JH; De Baets MH; Stassen MH; Houwertjes MC; Wierda JM Eur J Anaesthesiol; 2005 Aug; 22(8):591-6. PubMed ID: 16119595 [TBL] [Abstract][Full Text] [Related]
14. Immunisation with Torpedo acetylcholine receptor. Elfman L Prog Neurobiol; 1984; 23(1-2):39-62. PubMed ID: 6097937 [TBL] [Abstract][Full Text] [Related]
15. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897 [TBL] [Abstract][Full Text] [Related]
16. Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis. Gehi A; Benatar M; Langberg J J Cardiovasc Electrophysiol; 2008 Feb; 19(2):214-6. PubMed ID: 17711430 [TBL] [Abstract][Full Text] [Related]
17. A Diagnostic Dilemma of Dysphonia: A Case Report on Laryngeal Myasthenia Gravis. Khan AA; Khan MW; Kundi TA; Khan AW; Ali-Qazalbash ZM Cureus; 2021 Aug; 13(8):e16878. PubMed ID: 34513453 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis. Losen M; Stassen MH; MartÃnez-MartÃnez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851 [TBL] [Abstract][Full Text] [Related]
19. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations. Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872 [TBL] [Abstract][Full Text] [Related]